Impact of Mindfulness-Based Stress Reduction Meditation Practice on Patients After Cardiac Rehabilitation. (CARDIO-MBSR)

January 20, 2025 updated by: Elsan

Impact of Mindfulness-Based Stress Reduction Meditation Practice on Medium- and Long-term Follow-up of Cardiac Patients After Cardiac Rehabilitation.

Cardiac rehabilitation is a major component of treatment for patients suffering from coronary pathology revealed by myocardial infarction or acute coronary syndrome warranting transluminal coronary angioplasty, as well as in the aftermath of cardiac surgery.

A significant proportion of patients in this situation (40%) suffer from varying degrees of anxiety and depression, which are difficult to treat. These impair their quality of life and can make it more difficult for them to take part in the rehabilitation program, compromising the results that can be expected. Finally, they are often associated with lax compliance with medical treatment, less control of risk factors and less regular exercise.

Cardiac rehabilitation teams are well aware of this anxiety-depressive picture, and various therapies such as sophrology, relaxation and yoga have been proposed as alternatives to conventional medical treatments to help patients through this period.

Among these alternatives is the concept of "Mindfulness-Based Meditation", based on the Mindfulness-Based Stress Reduction (MBSR) protocol described by Dr. JKabat Zinn.

It has been the subject of several prospective randomized studies, which have demonstrated that it is suitable for the management of patients in this situation, and that it has measurable beneficial effects on their sense of well-being.

To our knowledge, the MBSR program used in cardiac rehabilitation has never been the subject of a randomized comparative study in France to assess its effectiveness on medium- and long-term anxiety-depressive disorders. This is the objective of this study.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

74

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Bernard Truong, MD

Study Contact Backup

Study Locations

      • Aressy, France, 64320
        • Recruiting
        • Clinique d'Aressy
        • Contact:
          • Bernard Truong, MD
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Cardiac patients eligible for cardiac rehabilitation,
  2. Patient with a Hospital Anxiety and Depression Scale (HADS) score for the anxiety dimension (HADS-A) >7 or a score for the depression dimension (HADS-D) > 7
  3. Age ≥ 18 years
  4. Affiliated with a social security scheme or beneficiary of such a scheme
  5. Patient signed free and informed consent form

Exclusion Criteria:

  1. Patients already treated for severe psychiatric disorders (major depression, psychosis, schizophrenia)
  2. Inability to follow the 8-week MBSR program
  3. Protected patient: minor, adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision
  4. Medical conditions which may interfere with the conduct of the study and the investigator's judgment, and which may render the patient unfit to participate in the study.
  5. Pregnant or breast-feeding patient
  6. Refusal to participate in the study or inability to comply with the study protocol for any reason whatsoever

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cardiac rehabilitation with Mindfulness-Based Stress Reduction (MBSR)
Conventional cardiac rehabilitation over 4 weeks with the introduction of MBSR over 8 weeks

The MBSR program is as follows:

  • 8 weekly group sessions of 2h30 led by the mindfulness instructor,
  • Sessions of around 45 minutes a day to be carried out by the patient, at home, for personal training,
  • An intensive day between the 6th and 7th sessions to explore certain practices more intensively, in order to support participants in effectively integrating mindfulness meditation into various life situations.
Active Comparator: Conventional cardiac rehabilitation
Conventional cardiac rehabilitation over 4 weeks
The usual cardiac rehabilitation program combines exercise training and therapeutic education workshops, with a daily session for four weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline of HADS anxiety and depression scores
Time Frame: Baseline and 12 months
HADS (Hospital Anxiety and Depression Scale) is a self questionnaire including 14 items which identifies and quantifies the depression and anxiety from which a person suffers.
Baseline and 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To assess the quality of life
Time Frame: Baseline, 1 month, 6 months and 12 months
The patients' quality of life will be measured by the MQOL-R questionnaire, which is a 14-point tool forming 4 subscales: physical, psychological, existential and social.
Baseline, 1 month, 6 months and 12 months
Medical treatment compliance
Time Frame: Baseline, 1 month, 6 months and 12 months
The patients' compliance to their medical treatment will be measured by the GIRERD self-questionnaire including 6 questions, to assess compliance, i.e. whether treatment is taken regularly and as prescribed.
Baseline, 1 month, 6 months and 12 months
Changes from baseline of cardiac risk factor "fasting blood glucose"
Time Frame: Baseline, 1 month, 6 months and 12 months
fasting blood glucose (in g/L)
Baseline, 1 month, 6 months and 12 months
Changes from baseline of cardiac risk factor "glycosylated hemoglobin"
Time Frame: Baseline, 1 month, 6 months and 12 months
glycosylated hemoglobin (% of total hemoglobin)
Baseline, 1 month, 6 months and 12 months
Changes from baseline of cardiac risk factor "Lipid profile LDLc"
Time Frame: Baseline, 1 month, 6 months and 12 months

Low Density Lipoprotein cholesterol (g/l)

  • Tobacco consumption (in packs.year)
  • BMI
  • Ricci Gagnon scale and 6-minute walk test
Baseline, 1 month, 6 months and 12 months
Changes from baseline of cardiac risk factor "Lipid profile HDLc"
Time Frame: Baseline, 1 month, 6 months and 12 months
High Density Lipoprotein cholesterol (g/l)
Baseline, 1 month, 6 months and 12 months
Changes from baseline of cardiac risk factor "BMI"
Time Frame: Baseline, 1 month, 6 months and 12 months
BMI ( weight and height will be combined to report BMI in kg/m2)
Baseline, 1 month, 6 months and 12 months
Changes from baseline of cardiac risk factor "effort"
Time Frame: Baseline, 1 month, 6 months and 12 months
6-minute walk test
Baseline, 1 month, 6 months and 12 months
Changes from baseline of cardiac risk factor "activity"
Time Frame: Baseline, 1 month, 6 months and 12 months
Ricci Gagnon scale: self questionnaire including 9 questions to evaluate if the subject has an inactive, active or very active profile
Baseline, 1 month, 6 months and 12 months
Changes from baseline of cardiac risk factor "Tobacco consumption"
Time Frame: Baseline, 1 month, 6 months and 12 months
Tobacco consumption (in packs.year)
Baseline, 1 month, 6 months and 12 months
Changes from baseline of cardiac risk factor "Blood pressure measurement"
Time Frame: Baseline, 1 month, 6 months and 12 months
Blood pressure
Baseline, 1 month, 6 months and 12 months
To assess the patient's anxiety
Time Frame: Baseline, 1 months and 6 months
HADS anxiety score
Baseline, 1 months and 6 months
To assess the patient's depression
Time Frame: Baseline, 1 months and 6 months
HADS depression score
Baseline, 1 months and 6 months
To evaluate the continuation of formal and informal mindfulness meditation practices in patients who have benefited from the MBSR program.
Time Frame: 3 months, 6 months and 12 months

Patients of the MBSR group will be asked two questions :

"Do you still do formal meditation practices?" "Do you still do informal meditation practices?"

3 months, 6 months and 12 months
To evaluate the patient's "mindfulness" and its impact on vital aspects in patients who have benefited from the MBSR program.
Time Frame: 3 months, 6 months and 12 months

FFMQ (Five Facets Mindfulness Questionnaire) questionnaire, which includes 39 questions, which assess the 5 facets which constitute mindfulness as a construct:

  • Describe the experience: talk about the experience in words.
  • Acting mindfully: performing actions with active attention to each step.
  • Non-judgment: absence of positive or negative comments on the thoughts and emotions experienced.
  • Non-reactivity to private events: allowing thoughts and emotions to exist without responding to them automatically.
  • Observation: remaining aware and focused on the experience, even when it is aversive or painful.
3 months, 6 months and 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 12, 2024

Primary Completion (Estimated)

November 12, 2026

Study Completion (Estimated)

November 12, 2026

Study Registration Dates

First Submitted

May 23, 2024

First Submitted That Met QC Criteria

May 29, 2024

First Posted (Actual)

May 31, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 20, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CARDIO-MBSR

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiac Disease

Clinical Trials on Cardiac rehabilitation with Mindfulness-Based Stress Reduction (MBSR)

Subscribe